Congenital myopathy is a group of rare inherited muscle diseases present from birth, caused by genetic mutations that disrupt the normal structure of muscle fibers. Unlike muscular dystrophies, which progressively destroy muscle tissue over time, congenital myopathies primarily affect how muscle cells are built and organized internally. The pooled prevalence across all ages is roughly 1.6 per 100,000 people, rising to about 2.8 per 100,000 in children.
What Happens Inside the Muscle
In a healthy muscle fiber, proteins are arranged in precise repeating units that slide past each other to generate force. In congenital myopathy, genetic mutations cause structural abnormalities within these fibers. Depending on the specific mutation, muscle cells may develop rod-shaped protein clumps, hollow zones where energy-producing components are missing, or misplaced cell nuclei that interfere with normal contraction.
These structural defects are present from the earliest stages of development, which is why babies are typically affected at or shortly after birth. The muscle fibers form, but they don’t work properly. In most forms the muscle tissue isn’t actively breaking down the way it does in dystrophies. Instead, it was never quite right to begin with.
Main Types of Congenital Myopathy
Congenital myopathies are classified into several subtypes based on what the muscle tissue looks like under a microscope and, increasingly, on the specific gene involved.
Core Myopathies
Core myopathies, including central core disease and multiminicore disease, are the most common subtype, affecting roughly 0.37 per 100,000 people across all ages. In these forms, sections of the muscle fiber are depleted of mitochondria, the tiny structures that supply energy. Under a microscope these depleted zones appear as “cores” running through the center of the fiber. Central core disease tends to produce large, single cores, while multiminicore disease creates many smaller affected patches. Core myopathies generally carry the best prognosis. Weakness typically does not get worse over time, and life expectancy is normal, though some individuals need a wheelchair.
Nemaline Myopathy
Nemaline myopathy is defined by the presence of tiny rod-shaped protein clumps inside muscle fibers. These rods are made of the same proteins normally found in the structural framework of the muscle cell, but they clump together abnormally instead of organizing into functional units. Severity ranges widely. Mild forms cause stable weakness and a normal lifespan. Moderate forms involve progressive weakness of the face, neck, and trunk but can still allow a near-normal life expectancy. Severe forms affect the breathing muscles and can lead to respiratory failure.
Centronuclear Myopathy
In centronuclear myopathy, the nuclei of muscle cells sit in the center of the fiber rather than at the edges where they belong. The most severe version, linked to a gene on the X chromosome and primarily affecting boys, is also called myotubular myopathy. Most children with this form do not survive beyond the first year of life. Other inheritance patterns produce milder disease with a longer lifespan.
Congenital Fiber-Type Disproportion
This subtype is characterized by an abnormal size difference between the two main types of muscle fibers. It affects roughly 0.23 per 100,000 people and can overlap with features of other congenital myopathies.
Symptoms and Early Signs
The hallmark of congenital myopathy is hypotonia, or “floppiness,” noticeable at birth or within the first year of life. Babies may have a weak cry, difficulty feeding and swallowing, and poor head control. As infants grow, they typically reach motor milestones like sitting, crawling, and walking later than expected.
In milder cases, a child may walk independently but seem clumsy or tire easily. In moderate cases, children often develop contractures (stiffened joints) and may need a wheelchair before age 10. In the most severe presentations, newborns have very limited movement, struggle to breathe on their own, and may not survive the first two years.
Facial weakness is common across many subtypes, giving the face a long, flat appearance. Breathing problems are a major concern in nearly every form. Respiratory muscle weakness is often worse during sleep, showing up as snoring, morning headaches, or excessive daytime sleepiness before it becomes obvious during waking hours. Respiratory insufficiency is the leading cause of death in congenital myopathy.
How It Is Inherited
Congenital myopathies are genetic, meaning they are passed from parents to children through mutated genes. The inheritance pattern depends on the specific gene involved. Some forms follow an autosomal dominant pattern, where one copy of the mutated gene from one parent is enough to cause disease. Others are autosomal recessive, requiring a mutated copy from both parents. The severe X-linked form of centronuclear myopathy passes through the mother’s X chromosome, which is why it overwhelmingly affects boys.
The gene affected in each type largely predicts the severity and features of the disease. For instance, mutations affecting the protein that controls calcium release in muscle cells are linked to core myopathies, while mutations in proteins that form the structural scaffolding of the muscle fiber tend to produce nemaline myopathy.
How It Is Diagnosed
Diagnosis typically starts with a clinical exam noting hypotonia and weakness, followed by a combination of muscle biopsy and genetic testing. A muscle biopsy involves taking a small sample of tissue and examining it under a microscope with specialized stains. One stain highlights rod-shaped protein clumps characteristic of nemaline myopathy. Another reveals the energy-depleted cores of core myopathy. The shape of shrunken muscle fibers also helps distinguish myopathy from nerve-related conditions: round small fibers point toward a muscle problem, while angular small fibers suggest a nerve problem.
Genetic testing has transformed the diagnostic process. Next-generation sequencing, which can scan hundreds of genes simultaneously, now achieves a diagnostic yield of roughly two-thirds of tested patients. Multi-gene panels and whole exome sequencing allow doctors to identify the precise mutation without relying solely on biopsy findings, which can sometimes overlap between subtypes. Classification increasingly depends on genetic data rather than microscopy alone.
Management and Daily Life
There is currently no cure for congenital myopathy, so management focuses on maximizing function and preventing complications. The specifics depend on which muscles are affected and how severely.
Breathing support is often the most critical piece. Because respiratory muscle weakness tends to worsen during sleep, many people benefit from nighttime ventilation through a mask. During respiratory illnesses, infants and children may need more aggressive support. Regular pulmonary function testing helps track changes over time, and consulting a pulmonologist experienced with neuromuscular disease is standard practice.
Scoliosis develops in many people with congenital myopathy as weakened trunk muscles fail to support the spine during growth. Bracing can slow the curve, but surgical correction with spinal fusion is sometimes necessary. Timing matters because the breathing muscles may already be compromised, making surgery riskier if it’s delayed too long.
Physical therapy and stretching help maintain joint mobility and slow the development of contractures. Surgery to correct foot deformities or release tight tendons is common. Assistive devices, from ankle braces to wheelchairs, are matched to the individual’s level of function. Many people with milder forms remain ambulatory throughout life with appropriate support.
Outlook by Severity
Prognosis varies enormously depending on the subtype and severity. People with mild nemaline myopathy or central core disease often have stable weakness and a normal lifespan. Those with moderate forms may experience slowly progressive weakness but can still live well into adulthood with proper respiratory monitoring and orthopedic care.
At the severe end, particularly with X-linked centronuclear myopathy or severe nemaline myopathy, respiratory failure in infancy is the primary threat. Arthrogryposis (multiple joint contractures at birth) combined with severe breathing difficulty is associated with death within the first two years. Between these extremes, many children grow into adults who manage their condition with a combination of respiratory support, physical therapy, and periodic surgical interventions.
Late-onset forms also exist. Some adults are diagnosed only after detailed questioning reveals a childhood history of mild floppiness or delayed milestones that were never fully investigated.